Find your next paid study

University of UtahNCT06389240

Actual pay is set by the research site.

Parent-Child RelationsChild Maltreatment

Child-Adult Relationship Enhancement in Primary Care: Supporting Parents and Children

The purpose of this study is evaluate the effectiveness of PriCARE/CARIÑO to reduce child maltreatment, improve parent-child interactions, and reduce harsh/neg…

University of North Carolina, Chapel HillNCT05233150

Actual pay is set by the research site.

The SUDC Registry and Research Collaborative

The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 1…

Sudden Unexplained Death SyndromeSudden Unexplained Death in Childhood

NYU Langone HealthNCT03109197

~$10 – $1,125

Actual pay is set by the research site.

Healthy Family Project: Ending Tobacco Use and Smoke Exposure in Asian American Communities

This study evaluates whether the Smokefree Family Living (SFL) intervention improves quit rates (smoking cessation) and exposure to tobacco contamination that …

University of California, San FranciscoNCT07049757

~$10 – $675

Actual pay is set by the research site.

ObesityInsulin SensitivityMuscle Weakness+2 more

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

The goal of this intervention study is to learn about how weight loss impacts molecular signaling of intermuscular adipose tissue (IMAT) in individuals with ob…

University of Colorado, DenverNCT06129110

Actual pay is set by the research site.

Acute Lower Limb Arterial Occlusion

The Artix All-in-one Solution for Complete thrombEctomy With eNDovascular Approach

This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients w…

~$10 – $1,125

Actual pay is set by the research site.

Inari MedicalNCT07135895

Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes

HM2023-05: GTB-3650 (Anti-CD16/IL-15/Anti-CD33) Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML)

This is a Phase I dose finding study of GTB-3650 (anti-CD16/IL-15/anti-CD33) Tri-Specific Killer Engager (TriKE®) for the treatment of select CD33-expressing r…

Masonic Cancer Center, University of MinnesotaNCT06594445

~$150 – $3,000

Actual pay is set by the research site.

A Phase I First-in-human Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Antiviral Activity of the Broadly Neutralizing Antibody BNT351 in Adults Living Without and With HIV

This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will a…

HIV -1 Infection

~$500 – $11,250

Actual pay is set by the research site.

BioNTech SENCT07392372

Pancreatic Adenocarcinoma Metastatic

Phase 1b Dose Escalation Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine…

Oncomatryx Biopharma S.L.NCT07377045

~$150 – $4,200

Actual pay is set by the research site.

Chronic Graft Versus Host Disease

Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

This is an open-label phase I study of fostamatinib in combination with ruxolitinib for the treatment of chronic GvHD with a suboptimal response to corticoster…

Stefanie Sarantopoulos, MD, PhD.NCT06233110

~$150 – $4,500

Actual pay is set by the research site.

Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Preschool Age

Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and…

Fragile X Syndrome

Children's Hospital Medical Center, CincinnatiNCT05957549

~$10 – $675

Actual pay is set by the research site.

Improving Outcomes in Chronic Intestinal Failure Using the ECHO Model: The LIFT-ECHO Last Mile Project

This is a multi-site research study to evaluate the efficacy and effectiveness of the LIFT-ECHO program to improve clinical outcomes in patients and improve pa…

Intestinal Failure